Aptevo Therapeutics APVO
NASDAQ APVO
$1.62 +0.00 (+0.31%)
As of: Oct 21, 2026 · 1:36 PM EDT

Aptevo Therapeutics (APVO) Deferred Taxes (2015 - 2017)

Updated

Aptevo Therapeutics' Deferred Taxes was -$7.49 million in Q4 2017, compared with -$15.31 million a year earlier.

Analysis

Aptevo Therapeutics (APVO) Deferred Taxes (2015 - 2017) Analysis & Trends

For FY2017, Deferred Taxes at Aptevo Therapeutics came in at -$2,000.

  • In earlier years, Deferred Taxes was -$15.82 million in FY2016 and -$1.36 million in FY2015.
  • The Q4 2017 figure marks the highest quarterly Deferred Taxes since Q3 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,135.59 Bn 1,104.17 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 616.92 Bn 535.45 Bn 17.26 Bn -479.00 Mn
3 AbbVie 501.52 Bn 474.63 Bn 12.70 Bn -195.00 Mn
4 Merck 367.36 Bn 321.74 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 297.93 Bn 261.92 Bn 11.24 Bn -
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn -
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 190.72 Bn 164.92 Bn 6.22 Bn -587.00 Mn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn -1.32 Bn
10 Aptevo Therapeutics 1.94 Mn -65.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -7.49 Mn
Dec 31, 2016 -15.31 Mn
Sep 30, 2016 -483,000.00
Jun 30, 2016 -11,000.00
Mar 31, 2016 -12,000.00
Dec 31, 2015 -667,000.00
API Access

Aptevo Therapeutics Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=APVO&period=max&api_key=YOUR_API_KEY